Pharma Times

APRIL 30, 2021

Health Secretary reveals government’s plans for UK life sciences 'transformation'

Genome 123

Genome Genomics Life Science 123

Drug Discovery Today

OCTOBER 27, 2022

27, Vilnius will host the EFIB’2022 event which will bring the European life science sector together. In the field of life sciences, Lithuania is best known for the discovery of gene scissors by Prof. Lab, focused on research and development of novel genome editing tools. Virginijus Šikšnys.

Genome 85

Genome Genomics Gene Editing Life Science 85

Pharmaceutical Technology

SEPTEMBER 15, 2022

From the Human Genome Project to contemporary drug development, collaboration is critical to the life sciences. It is also an important factor in the success of life sciences clusters, where a high concentration of pharmaceutical or medical device companies can all be found in one district, city or region.

Life Science 130

Life Science Drug Delivery Genome Project Development 130

Medical Xpress

APRIL 11, 2023

With the huge abundance of genomic data generated from life science experiments, processing large datasets remains a challenge in the field of bioinformatics.

Genome 75

Genome Genomics Bioinformatics Life Science 75

XTalks

AUGUST 24, 2022

This episode features an interview with Dr. Asaf Zviran, CEO and co-founder of C2i Genomics, a biotech company focused on improving cancer detection and monitoring using genomics- and AI-based approaches. Zviran’s founded C2i Genomics, including a personal story, and how the company is focused on truly personalizing cancer treatments.

Genome 52

Genome Genomics Life Science 52

XTalks

DECEMBER 20, 2023

As we step into 2024, the life sciences continue to evolve at an unprecedented pace, driven by technological innovation, a deeper understanding of human biology and the application of new technologies in areas like drug development and health wearables. These companies are at various stages of research and clinical trials.

Life Science 119

Life Science Gene Editing Development Clinical Trials 119

XTalks

NOVEMBER 10, 2020

For more information on tackling this “genomic analysis bottleneck,” watch this on-demand webinar. HS: Due to the heterogeneity of the rare disease population, there are many relevant gene lists, and the genomic data analysis of these patients covers almost 2,000 different genetic targets.

Genomics 98

Genomics Genome Medicine Genetic Disease 98

XTalks

JUNE 12, 2024

Subscribe to the Xtalks Life Science Podcast to never miss a new episode. It leverages various patient-specific factors, including genetics, age, weight, organ function and even lifestyle, to determine the most appropriate dosage for each individual.

Life Science 97

Life Science Pharmacy Doctors Doctor 97

pharmaphorum

MARCH 8, 2022

How did you get into life sciences? After a few years, I decided I wanted to move into the commercial side of the business, so I completed an MBA and went on to hold various positions in Corporate Business Development, Life Science and Healthcare. What has your career path been? Ultimately, this has to start at school.

Life Science 98

Life Science Engineer Scientist Doctors 98

BioTech 365

FEBRUARY 23, 2021

ERS Genomics and G+FLAS Life Sciences sign CRISPR/Cas9 license agreement ERS Genomics and G+FLAS Life Sciences sign CRISPR/Cas9 license agreement G+FLAS Life Sciences is applying CRISPR technology to develop research tools and reagents DUBLIN & SEOUL–(BUSINESS WIRE)–ERS Genomics Limited, which … Continue reading →

Life Science 40

Life Science Genome Genomics Licensing 40

Drug Discovery Today

MAY 26, 2023

BARCELONA/LONDON, 25.05.23: Seqera Labs, the leading provider of secure workflow orchestration software in the life sciences sector, has partnered with Genomics England, the government-owned company that launched the 100,000 Genomes Project in partnership with the NHS.

Genome 45

Genome Genomics Genome Project Research 45

BioSpace

JULY 28, 2021

Biopharma and life sciences companies from across the globe provide updates on their pipelines and business operations including Takeda, Origin Therapeutics, ERS Genomics and more.

Life Science 97

Life Science Genome Genomics 97

BioTech 365

JANUARY 10, 2022

Nashville Biosciences and Illumina Announce Agreement to Establish Preeminent Clinico-Genomic Resource for Life Sciences Research & Development Nashville Biosciences and Illumina Announce Agreement to Establish Preeminent Clinico-Genomic Resource for Life Sciences Research & Development NASHVILLE, Tenn.–(BUSINESS

Life Science 40

Life Science Genome Genomics Development 40

The Pharma Data

JANUARY 31, 2021

(NASDAQ: ILMN), the global leader in DNA sequencing and array-based technologies, and Sequoia Capital China , a leading investment firm, today announced a collaboration to catalyze the startup ecosystem in China with the launch of the Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by Illumina.

Genome 52

Genome Genomics Life Science DNA 52

XTalks

MARCH 21, 2025

Lee Honigberg on the Future of Blood-Based Biomarker Assays GeneDX GeneDX recently integrated AI (Multiscore) into its interpretation platform, improving speed and accuracy in analyzing complex genomic data. 10x Genomics 10x Genomics reported $707 million in 2024 revenue.

Genome 59

Genome Genomics FDA Approval Trials 59

Roots Analysis

AUGUST 28, 2022

The up-and-coming field of spatial genomics in biology promises to bridge the gap between high plex, high throughput, and high resolution. 70+ spatial Genomics solutions are developed by industry and non-industry players. 70+ spatial Genomics solutions are developed by industry and non-industry players. Concluding Remarks.

Genome 52

Genome Genomics RNA Genome Project 52

BioSpace

JANUARY 31, 2021

Illumina, the world’s leading DNA sequencing and array-based technologies company, is partnering with Sequoia Capital China, an investment firm, to launch a life sciences incubator in China. It is dubbed the Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by Illumina.

Life Science 51

Life Science DNA Genome Genomics 51

The Pharma Data

JANUARY 31, 2021

Illumina , the world’s leading DNA sequencing and array-based technologies company, is partnering with Sequoia Capital China, an investment firm, to launch a life sciences incubator in China. It is dubbed the Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by Illumina.

Life Science 52

Life Science Genome Genomics Reagent 52

BioTech 365

JULY 27, 2021

Bio-Rad and 10x Genomics Announce Settlement to Resolve Multiple Litigations Bio-Rad and 10x Genomics Announce Settlement to Resolve Multiple Litigations HERCULES, Calif.–(BUSINESS NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, … Continue reading →

Genome 40

Genome Genomics Life Science Production 40

pharmaphorum

OCTOBER 7, 2021

However, developments in genomic medicine are making huge strides to improve this situation, and these will also be discussed during the webinar. Dr Joanne Hackett is the head of genomic and precision medicine at IQVIA and previously was chief commercial officer at Genomics England. About IQVIA.

Genome 98

Genome Genomics Medicine Life Science 98

STAT News

APRIL 6, 2023

Our colleague Matthew Herper joins us for a deep dive into Illumina, explaining how the biggest company in genome sequencing lost the faith of shareholders and painted itself into a corner.

Life Science 98

Life Science Genome Genomics 98

Drug Discovery Today

OCTOBER 27, 2022

27, Vilnius will host the EFIB’2022 event which will bring the European life science sector together. In the field of life sciences, Lithuania is best known for the discovery of gene scissors by Prof. Lab, focused on research and development of novel genome editing tools. Virginijus Šikšnys.

Genome 40

Genome Genomics Gene Editing Life Science 40

pharmaphorum

MAY 6, 2022

The PING Conference 2022 is back in person this year, with opportunities to network face-to-face with people from right across the life sciences ecosystem. Hear about how the UK is leading the way in what has been described as the ‘Golden Age for Life Sciences Innovation’ and the opportunities arising from this from leading experts.

Life Science 52

Life Science Genome Genomics Production 52

BioTech 365

JANUARY 7, 2021

Crown Bioscience Expands Genomics and Next Generation Sequencing (NGS) Capabilities To Streamline Translational Biomarker Discovery Workflows Crown Bioscience Expands Genomics and Next Generation Sequencing (NGS) Capabilities To Streamline Translational Biomarker Discovery Workflows SAN DIEGO–(BUSINESS WIRE)–Crown Bioscience, a JSR Life (..)

Genome 40

Genome Genomics Life Science 40

Drug Discovery Today

AUGUST 5, 2021

HumGut comprises a collection of about 30,000 genomes, covering the broad diversity of bacterial genomes found in the human gut. This work is funded by the Norwegian University of Life Sciences (NMBU) and GA with support from the Research Council of Norway through an Industrial PhD program.

Genetic Analysis 40

Genetic Analysis Genome Genomics Genetics 40

pharmaphorum

JULY 26, 2021

DeepMind partnered with the European Molecular Biology Laboratory (EMBL) to come up with the AlphaFold database, which predicts the three-dimensional structures of the human proteome – nearly all (98.5%) of the 20,000 or so proteins expressed by the human genome.

Protein 130

Protein Genome Genomics Life Science 130

XTalks

JUNE 1, 2022

This involves the integrated analysis of several layers of biological data, including genomic, proteomic, transcriptomic and phosphoproteomic data using novel transomics technologies involving lab methods and AI approaches. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 52

Life Science Genome Genomics Drugs 52

XTalks

MAY 23, 2024

Eterovic brings much knowledge and experience to the table, having led the development of a new Oncology Diagnostic program at Eurofins Viracor that integrates the latest genomic profiling techniques. Eterovic highlights that the financial and logistical barriers to comprehensive genomic profiling are high but not impossible to overcome.

Genetics 114

Genetics Research Genome Genomics 114

XTalks

MAY 22, 2024

John Finn, PhD Chief Scientific Officer Tome Biosciences Dr. Finn has over 20 years of experience in the gene therapy space with a focus on genome editing and delivery technologies. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Gene Editing 52

Gene Editing Life Science Gene Gene Therapy 52

XTalks

FEBRUARY 1, 2021

The move follows the 2019 merger between Caprion and HistoGeneX , a Belgian histopathology and genomics lab. While Caprion-HistoGeneX’s name change to CellCarta kicked off 2021, it followed a trend of life science companies rebranding that started last year.

Life Science 98

Life Science Branding Genome Genomics 98

XTalks

AUGUST 29, 2022

CRISPR is notable for engineering living cells, allowing scientists to edit, turn off, delete, or replace genes in a cell’s genome. It is difficult to control where the viral vectors insert genes in the genome, and it is difficult to manufacture large quantities of clinical-grade viral vectors. From the Bench to Patient Therapeutics.

Gene Editing 98

Gene Editing DNA Gene Genome 98

XTalks

SEPTEMBER 9, 2021

It was found that the gene being delivered through the therapy had integrated into the genomes of six of the seven mice that were administered the highest dose. Although a rare event that occurs at very low frequency, AAV vectors can integrate into genomes through homologous recombination.

Gene Therapy 105

Gene Therapy Gene Genome Genomics 105

XTalks

MAY 12, 2021

The team debates the ethical considerations around epigenetic therapies and genome editing, and how scientific communications should be improved to help educate the public on complex medical breakthrough. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 40

Life Science Gene Expression Gene DNA 40

pharmaphorum

MARCH 19, 2021

As data and digital technology become vital to every aspect of life sciences, the industry is increasingly looking beyond biologists, chemists, and doctors to drive its drug development – and finding that technology has a chief role to play in the future of medicine. on Big data: astronomical or genomical? ,

Bioinformatics 59

Bioinformatics Drugs Genome Genomics 59

XTalks

DECEMBER 14, 2022

The CRISPR-Cas9 gene editing system uses a programmable single guide RNA sequence (sgRNA) to find and bind to specific regions of DNA and the Cas9 nuclease induces double strand breaks at these target regions of the genome. An RNA strand guides Cas9 to cut at a particular genomic site and insert the landing site, which is 46 DNA base pairs.

Gene Editing 98

Gene Editing DNA Gene Gene Sequencing 98

BioTech 365

NOVEMBER 17, 2021

Matt Posard Joins Vizgen Board of Directors Matt Posard Joins Vizgen Board of Directors Single-cell spatial genomics instrument pioneer appoints genomics commercialization expert CAMBRIDGE, Mass.–(BUSINESS

Genome 40

Genome Genomics Life Science 40

pharmaphorum

AUGUST 11, 2022

There have been great strides made in genomics to refine tools that determine the safest, most effective course of treatments for patients across a number of disease states. Looking at an individual’s genomic profile also provides an understanding of appropriate medication dosage.

Genome 98

Genome Genomics Drugs Genetics 98